On Chinese-English Translation Strategies of Biopharmaceutical Corporate Profiles Guided by Adaptation Theory

With the closer economic ties between countries and the spread of epidemics such as COVID-19, Chinese pharmaceutical enterprises have a potential international market. The quality of the English translation of pharmaceutical company profiles is of great significance to the development of international market and human health. Compared with 8 Chinese and 8 English pharmaceutical company profiles, there are significant different focuses. Besides the basic information, Chinese pharmaceutical company profiles stress the history and awards of the companies, while English pharmaceutical company profiles are centered on the effective information. The existing C-E translation problems lie in word-for-word translation, lack of logic between sentences or text and redundancy. Guided by adaptation theory, the following conclusions are drawn: on syntax level, when translating, the translator should apply the methods of creative translation, clarify the logical relationship between clauses, adjust the word order of sentences and appropriately add logical conjunctions. On discourse level, the translator can use creative translation— recompose the information of the profiles. Besides, we should emphasize the company’s care for life and health. Only in this way can contextual relations and linguistic structure be adapted. I hope it will be helpful to the English translation of the profiles of Chinese pharmaceutical enterprises.


Introduction
Now the world is plagued by COVID-19, pharmaceutical companies have a huge potential international market. However, if Chinese enterprises want to enter international markets successfully, they must first improve their own international visibility and the trust of potential consumers and partners. Therefore a good company profile is conductive to achieving the aforementioned purposes. Corporate profile is just like the visiting card of a company. It not only shows the image of the company, but also stimulates their desires to purchase or cooperate, which determines the publicity effect and even the economic benefits of the company to a certain extent. But at present, there are various problems in the translation of pharmaceutical enterprise profiles, which makes it difficult to play its due role. Adaptation theory is a guide to the choice of language when translating. Based on the previous research results and guided by the Adaptation theory, this paper puts forward corresponding and feasible English translation strategies for the profiles of pharmaceutical companies, so as to promote Chinese companies to "go global" better.

Overview of Enterprise Translation Research
In the early 1990s, Liu Xiangang first proposed to conduct theoretical research on enterprise translation in China, and repeatedly called for the establishment of a specialized discipline to conduct research on it. By publishing articles, he demonstrated the necessity and possibility of establishing enterprise translation studies, and set up a basic framework, which played an significant role in promoting the establishment of enterprise translation studies afterwards. Led by him, enterprise translation began to receive more and more scholars' attention, and gradually developed into a new sub-discipline of translation. Some scholars conduct research from the nature of enterprise translation. For example , Li Guishan (2002) demonstrated that the most important feature of enterprise translation should be utilitarianism by showing the characteristics and concrete performance of it. By arguing that the knowledge, specialized vocabulary and customary expressions required for translation are different from those of technical English, he contended that corporate translation should not be the same as technical translation. It also pointed out the necessity and importance for enterprises to have and cultivate their own specialized translation teams. All these studies have enhanced the guiding significance of adaptation theory to corporate translation practice.
Some scholars use other theories to guide the practice of corporate translation. For example, Wen and Chen (2003) used the reception aesthetics theory and single out some translation suggestions. Xu Jianzhong's book Translation Practices for Industrial and Commercial Enterprises introduces the process of enterprise translation development to industry recognition, analyzes the characteristics of corporate translation, summarizes the principles of corporate translation, and finally proposes some translation strategies, which has far-reaching implications for the development of enterprise translation studies (Xu, 2002). Lv Lixian introduced the concept of parallel text and sorted out translation strategies according to the differences in structure, culture and language style between Chinese and English texts (Lv, 2016).

Shortcomings of Translation Studies on Corporate Profiles
Although more and more scholars have conducted translation studies of corporate profiles on the basis of corporate translation studies, for example, Jia Heping proposed the strategies of deletion, omission and rewriting by analyzing the linguistic, pragmatic and cultural translation errors in corporate profiles (Jia, 2014). However, most of them are based on Functional Equivalence Theory or Skopos Theory. For example, Huang Shihui, guided by Skopos Theory, summarized that the translation of company profile should follow the principle of purpose, the principle of translator's subjectivity and the principle of reader-oriented (Huang, 2012).
As we all know, the terminology and jargon of different industries varies from industry to industry. Accordingly, the terminology and emphasis in the profiles of different companies may also vary. Therefore, more research is in line with the need. Starting from Skopos Theory, Xie Li analyzes the discourse, pragmatic, and cultural problems in Henan Province's enterprise profiles and the causes behind them, and proposes corresponding translation strategies from the three aspects of translators, companies and society. Studies focusing on the translation of enterprise profiles of a certain type or region, are more in line with the current needs, but not in large numbers (Xie, 2014).
Among them, few scholars have studied the English translation of pharmaceutical enterprise profiles. For example, Chen Kailun summarized three common mistakes in the English translation of pharmaceutical company introductions based on the Reception Theory and with the target language readers as the center. He proposed to improve the acceptability of pharmaceutical company profiles by strictly selecting medical terms, appropriately supplementing them, omitting useless information, classifying main points, and highlighting key points. It has a certain guiding significance for the English translation of pharmaceutical company profiles, but there is still a broad research space to be developed (Chen, 2016).
In recent years, the impact of epidemics such as Ebola and COVID-19 has raised more concerns about life and health. Pharmaceutical companies have a broader market. Appropriate English translations of company profiles are helpful for pharmaceutical enterprises to go international, expand the market and strengthen communication.

Theoretical Framework
Adaptation Theory not only explains language phenomena at the macro level of cognitive culture and society, but also conducts research on selection and usage of language at all levels of language structure.

Core Concepts of Adaptation Theory
Verschueren believes that language has variability, negotiability, and adaptability. Variability means that language can be chosen. Negotiability means that the language can be chosen flexibly, rather than being made mechanically in accordance with certain formalities or strict rules. Adaptability refers to the flexibility of language users to adapt from the various possibilities available to them in order to meet the needs of communication. Variability and negotiability provide possibilities and methods for language selection. Adaptability can only be achieved on the basis of variability and negotiability. Adaptability, the core of the language use process, is the ultimate goal to be achieved in language use. These three characteristics are conducive to solving the translation problems such as the translatability (Yang, 2005).

The Research Perspective of Adaptation Theory
Verschueren put forward Adaptation Theory from four aspects: context, linguistic structure, translator, and the process of adaptation (Verschueren, 2005). This paper mainly introduces the contextual correlates of adaptability and structural objects of adaptability.

Contextual Correlates of Adaptability
Context refers to the environment in which language is used for communication. It is composed of a series of factors that adapt to discourse and influence the processing of discourse. It can be roughly divided into two parts. One is the language context, and the other is the communicative context.
The communicative context consists of mental, social, physical world and communicative parties. In the communicative context, communicative parties play an important role in the production and understanding of discourse (He, 2007).
The importance of communicative parties in communication is not only reflected in their social roles, but also in their choice of contextual components. The number and category of speakers have a direct impact on the expression of utterances and the comprehension of the interpreter. Whether the speaker is the only source or one of the sources of information is directly reflected in his choice of language (He, 2007). Next, the number of utterers also affects the discourse (He, 2007). Language users are not limited to the two parties of the conversation, but also to others related to the content of the conversation (Chen, 2001).
The physical world mainly refers to the influence of time and space on language choice. It consists of factors such as the time of the event, the time of the speech, the time of the reference, the position of the communicative parties in the physical world, the physical appearance and characteristics (Yang, 2006). A typical example is that we choose different greetings as the time of day and night changes.
The social world means that the choice of language is restricted by various principles and norms in social settings or institutions and social environments. In other words, the choice of language must conform to the communicative norms of the social settings or institution, the social environment and the linguistic society (Yan, 2006). The number and variety of social factors that need to be taken into account make adaptation more complex and dynamic.
The mental world involves the cognitive, emotional and other psychological states of the communicator, such as personality, desire, intention, motivation, concept, etc. The language selection process of one party in communication is a dynamic process of adapting to one's own and the other party's psychological world (Yang, 2006).
Linguistic context consists of cohesion, intertextuality and sequencing. Cohesion refers to the Journal of Social Science Studies ISSN 2329-9150 2021 realization of semantic relevance through methods such as reference, connection, repetition, omission, repetition, and contrast. Intertextuality refers to the restriction and influence of factors such as situation, style, theme on a text. Sequencing refers to the ordering of discourse to reflect the logical relationship of the original language (Yang, 2006).

Structural Objects of Adaptability
Language selection can occur at any level of its structure. First of all, it can occur on the symbol system, which includes both linguistic symbols in native or foreign language and nonverbal symbols such as gestures, eyes' expressions and so on. Then we choose oral or written channels of communication. Depending on who we communicate with and where we communicate, we choose different codes of speech such as dialects, jargon, idiomatic expressions. We also choose the degree of formality of the language according to factors such as the degree of formality of the conversation and the topic of discussion. Language features can also be affected by speech events. At the level of discourse, the structure and characteristics of the discourse are analyzed according to the category to which it belongs. At the syntactic level, attention should be paid to the choice of referential relations, discourse types, grammatical relations and so on. In terms of vocabulary, it is necessary to choose the lexical nature, meaning, and function of words and so on. Finally, attention needs to be paid to the selection of phonological features such as intonation and rhyme (He, 2007).
The construction principle of discourse depends on grammatical rules at the level of sentence, and at the level of the paragraph, it mainly takes the coherence and relevance of meaning as the principle (Ge, 2002). Through the adaptation of these choices, the target text is made to be close to the source language at all levels of language structure in order to achieve the purpose of communication.

Adaptation Theory and Translation Studies
Adaptation Theory not only explains language phenomena at the macro level of cognitive culture and society, but also conducts research on selection and usage of language at all levels. Therefore, the translator's translation activities can be regarded as his language choice based on the purpose of different communicative activities and at different levels of consciousness. Language choice can be either conscious or unconscious, and it can be influenced internally or externally. The use of language is equivalent to choices being made constantly (Verschueren, 1999).
In addition to the two-way communication characteristics of general communicative behavior, translation also has its uniqueness in time and space. The communication between the translator and the readers is not instantaneous in time and is dislocated in space (Chen, 2006).
Adaptation Theory fills the gap in translation studies in the previous analysis of the translator's transformation process. The proposal of Adaptation Theory has also affected the academic discussion on translation standards, making the principle of translation equivalence difficult to hold (Chen, 2006).
In short, Adaptation Theory aims to make language choice in line with the object of Journal of Social Science Studies ISSN 2329-9150 2021 communication, the environment of communication, and the purpose of communication in order to achieve successful cross-cultural communication, which is also the purpose of translation (Song, 2004).

Research Method
This study is conducted to understand the differences between Chinese and English pharmaceutical companies, hoping to shed some lights on the translation and publicity of Chinese pharmaceutical companies.

Research Questions
This paper will mainly examine the semantic, syntax and discourse characteristics of the corporate profile texts of Chinese and American pharmaceutical companies. We endeavor to answer the following questions: What are the typical features in the corporate profiles of Chinese pharmaceutical companies?
What are the typical features contained in the corporate profile text of English pharmaceutical company? How is it different from that of Chinese pharmaceutical companies?
In view of the above differences, how to translate Chinese pharmaceutical companies' corporate profiles into English is the focus of this paper.

Source of Corpora
This paper builds two micro corpora from the company profiles on the websites of 8 famous pharmaceutical companies in English (Appendix I) and the company profiles of 8 famous pharmaceutical companies in China (Appendix II).

Research Design
First, we select 8 Chinese and English pharmaceutical companies as our Chinese and English corpora. We use word cloud map to analyze the word frequency, trying to find out the differences of Chinese and English pharmaceutical companies. We analyze sentences and texts with qualitative research methods, in the hope that we can find some dissimilarities in Chinese and English pharmaceutical companies.

The Overview of Company Profiles
The company profile has a variety of expressions such as "Enterprise Profile", "About us" and "Company Introduction". Broadly speaking, its content can be divided into four parts, namely, who we are, what we do, how we do and what results we have achieved.
In the section of "who we are", we can learn about company's nature, size, employees, development history etc.. In the section of "what we do", we can know about its business scope, main products, and R&D capabilities. In the section of "how we do", we can learn about its history, such as its development purpose, development plan, future vision, etc. In the part of "what results we have achieved", we can learn about the operating status, sales Journal of Social Science Studies ISSN 2329-9150 2021 performance, honors and so on.
These specific information can be based on the actual situation of the enterprise, and is not indispensable. Company profile is a material for external publicity, but also an intermediary for the company to communicate with potential customers or partners. A successful company profile can deliver the information to readers concisely, orderly, and accurately, and give full play to its promotional function.

The Characteristics and Functions of Pharmaceutical Company's Profiles
The style of company profile is practical, and its greatest feature is practicality. The main point is to convey some substantive information to readers (Tang, 2000).
As a kind of corporate publicity, the corporate profile is bound to convey a large amount of basic information to readers, win their trust and favor, and then establish and/or develop customer relationships or partnerships. Ultimately the goal of corporate economic gains will be achieved.
Secondly, the company profile also has the following three distinctive features: stylized article format, diversified expression techniques, accurate, concise and standardized language style (Tang, 2000).
The language of the company profile shows the characteristics of accuracy, conciseness and standardization. The Chinese characters 简介 (jianjie), which means "brief introduction", embodies the limit of length of this style. Only a concise statement can be presented within a limited space. Company profiles tend to use data, which is an accurate way of showing the scale and strength of the company.
The expression of its language presents diverse characteristics. Companies can show their rich cultural connotations and unique corporate culture through rhetorical techniques such as comparison, rhyme and quoting classic poems or allusions. At the same time, enterprises also use slogans to deepen the impression of the target readers.
Apart from the above-mentioned basic content and features of general corporate profiles, the profile of pharmaceutical companies also has some unique features. First of all, there are more professional terms in the profiles of pharmaceutical companies. Secondly, information on scientific research investment, talent team, R&D bases, and projects under research take up a large proportion. Finally, pharmaceutical companies will definitely mention their contributions to society in their profiles to reflect their sense of social responsibility, such as donating funds to social public welfare undertakings including poverty alleviation, education assistance and assistance to the vulnerable groups.
Peter Newmark classified text into expressive text, informative text and vocative text according to the function of language and the purpose. Most texts have more than one type of functions. In general, there may be several functions in a particular text, one or two of which play a leading role, while the others play a supporting role. Enterprise profiles are actually a mixture of three types, with information and vocative functions dominating, followed by the expressive function. ISSN 2329-9150 2021 The core of informative text is the authenticity of the content, which reflects the objective facts to achieve the purpose of conveying information (Newmark, 2001).

Journal of Social Science Studies
The purpose of corporate profile is to provide the audience with the basic information about the enterprise, such as products and services, brands and advantages, so that the audience can have a comprehensive understanding of the enterprise in a short time.

Contrast Between Chinese and English Pharmaceutical Company Profiles
Chinese and English pharmaceutical corporate profiles are presented in the forms of different languages. Therefore, the content is more or less the same. As a kind of corporate publicity materials, both of them serve the purpose of corporate publicity and have the function of information transmission. However, there are inevitably some differences between Chinese and English due to different language, culture and context. Therefore, there are certain differences in words, sentences and text, such as the length of the content, the location of similar information, the language style, and the constituent elements of sentences. By collecting the profiles of 8 (Note 1) Chinese and foreign pharmaceutical company profiles respectively (see Appendix I and II), the corresponding word cloud maps were created (see the above Figure 1 and Figure 2). From the above figures, we can see that the word "health" is given the first priority and appears most frequently in foreign pharmaceutical companies' profiles, followed by "medicine", "people", "patients", "disease", and "care". In addition, these frequent words are nouns. This shows that they focus more on the concern of people's health. However, the most frequent words in the Chinese company profiles are "研发 (yanfa)", "创新 (chuangxin)", "医药 (yiyao)", "产品 (chanpin)". This shows that the company focuses on the R&D aspect and tries to show its strength. In Chinese, verbs, such as "研发 (yanfa)", "创新 (chuangxin)" and "制药 (zhiyao)" are more common.
There are a wealth of four-character chain structures, such as "不忘初心，牢记使命，砥砺奋 进 (bu wang chuxin,laoji shiming dili fenjin)" in Chinese pharmaceutical company profiles, which also can be found in the eight profiles in Appendix II.
On syntactic level, many sentences in Chinese corporate profiles have a more fixed expression. In terms of rhetorical devices, parallelism, metaphor and quotation are often seen. As in the Example 1, the underlined part is a very common sentence structure in Chinese Journal of Social Science Studies ISSN 2329-9150 2021 profiles. However, the English syntax, on the other hand, is more flexible and less likely to see such fixed expressions.
Series verb constructions and long sentences are ubiquitous in Chinese corporate profiles, and most of the paragraphs contain only one sentence, while short sentences is common in English pharmaceutical company profiles. Furthermore, "We" is frequently used as the subjects in foreign pharmaceutical company profiles.
On discourse level, the corporate profiles in English are short in length. The eight profiles of foreign pharmaceutical companies collected were less than 500 words in total, five of which were less than 300, while the Chinese profiles were all long. Five of the eight have more than 800 words, and three of them even exceed 1100.
Besides, subheadings are commonly-used in foreign pharmaceutical company profiles, and seven of the collected ones is comprised of several subheadings.

Syntactic Level
To understand Chinese sentence requires a certain ability to analyze and understand the context, because some sentences are loose without logical conjunctions. However, English emphasizes logic and often uses logical conjunctions to express the internal logic of the text. When translating, we need integrate the sentences, clarify the logical relationship between them, then choose the appropriate logical connectives, and adjust the order if necessary. Only after understanding the semantic relationship and figuring out the contextual logic can we achieve compliance with sequencing. The logical relationship of underlined sentence in the Example2 is hard to be seen literally. But from the English translation, the translator shows that the business revenue is realized on the basis of registered capital, employees and assets, which realizes the adaptation to the language structure of the target language.
It is also important to pay attention to the use of deduction within the sentence. The Chinese profile tends to list facts first and then summarize them. In English, deduction structure is often used. Therefore, when translating, we can insert a general phrase(including more than 100 enterprises at home and abroad) like Example3, which not only reflects the logic and conforms to the language structure of English, but also leaves the reader the choice of whether they need to continue reading in details.

Discourse Level
As mentioned above,of the eight collected foreign pharmaceutical company profiles, seven categorized the information and preceded the paragraphs with subheadings. Roughly, there are sections on leaders, values, culture, and history. Each section focuses on one topic. This not only reflects the hierarchy and intuition of the text, but also provides the reader with the convenience of selecting content of interest to them for further understanding based on the headings. In contrast, only one of the eight Chinese company did so, which are influenced by the Chinese language,culture or contexts. This structure, in most cases, does not conform to the linguistic expression habits of the target language and does not adapt to its linguistic structure. So we should first classify the overall content, extract the core points, and present them in the form of subheadings, and then arrange them according to the importance of the content.
In the previous chapter, we compared the word frequency differences between Chinese and foreign pharmaceutical company profiles and found that the profiles of foreign pharmaceutical companies emphasize more on humanistic concerns of the company. All of the eight foreign profiles have similar expressions. This reflects the intertextuality of the discussed topics.

Example 4:
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. (https://www.bms.com/about-us/our-company.html) Example4 is the first sentence in Bristol Myers Squibb's profile. Through this sentence, we can not only feel the humanistic care of the company, but also its willingness to innovate in pharmaceuticals and the confidence to overcome diseases, which skillfully win the readers' favor. Similar expressions account for a relatively large proportion of English pharmaceutical company profiles. This corresponds to the internal requirements of the text of the Journal of Social Science Studies ISSN 2329-9150 2021 pharmaceutical industry, which is closely related to the safety and health of human life.
However, the description of this type of information in the Chinese company profile is only one or two sentences. Some are even deleted directly in the English translation. This fails to be responsive to the language context, which is not conducive to attracting foreign potential customers. Therefore, when translating them, we should increase the length appropriately, pay attention to reflect the enterprise's concern for health and life, so that this key point can be highlighted.
On the contrary, Chinese companies often enumerate the honors they have received in their profiles to highlight the strengths and popularity of the company. Indeed, awards can show the strong points of the enterprise to a certain extent. However, this also led to the translation misconception that many enterprises blindly and literally translate all the awards they have received. The word cloud map in the previous chapter also shows that award-related words appear very rare in the profiles of foreign pharmaceutical companies. In fact, most foreign companies take customer reputation as the criterion to judge the strength of the company. Besides, many provincial awards are not as convincing as one might think. Affected by differences in social environments, it is difficult for foreign readers to understand the meaning of awards. Therefore, for the translation of awards and honors, we can choose one or two awards with international popularity and recognition for translation. In Example5, the English translation of Kelun's profile only translates its ranking in the whole Chinese industry. This kind of industry ranking is far more convincing for foreign readers than the latter two awards. For the latter two awards, which are unfamiliar to foreign readers, the translator directly adopted the provincial translation method. It is worth learning how to respond to the worldwide readers.

Conclusion
Firstly, the content, core concepts and research perspectives of Adaptation Theory are introduced. Then through the collection and analysis of the translation of pharmaceutical company profiles, the characteristics and functions of the company profile are summarized. Then, I collected eight Chinese and foreign pharmaceutical company profiles respectively and made word cloud maps to analyze the differences in word frequency and then the comparison and contrast on syntax and discourse level are analyzed.
The result shows: 1) On lexical level, more attention has been paid on people's health and Journal of Social Science Studies ISSN 2329-9150 2021 medicine in English pharmaceutical company profiles. However, Chinese companies focus on the R&D aspect and show three strengths. 2) On syntactic level, fixed expression,series verb constructions, rhetorical devices and long sentences are apt to be used in Chinese pharmaceutical company profiles, but short sentences and the subject "We" are given the first priority in English pharmaceutical company profiles. 3) On discourse level, English profiles are shorter in length than Chinese ones. Subheadings are commonly-used in foreign pharmaceutical company profiles, while subheadings are scarcely used in Chinese ones.In addition, the honors to highlight the strengths and popularity of the company are listed in Chinese pharmaceutical company profiles, while they seldom appear in the profiles of foreign pharmaceutical companies.
Based on the findings, more translation methods should be applied to translate four -character chain phrases in the profiles of Chinese pharmaceutical companies. In addition, we should emphasize the company's care for life and health. In terms of syntax, attention should be paid to clarify the logical relationship between sentences, change long sentences into short ones, add logical conjunctions, adjust the order of words, and also using creative translation to achieve adaptation of the language structure and language context of the target language. In terms of discourse, we should first classify the information in the text, and then extract the main points as subheadings. If necessary, some redundant information can be deleted. The information of honors can also be omitted or only retained several convincing ones. This paper has certain practical significance. At present, there are few related researches on the translation of pharmaceutical company profiles. Pharmaceutical companies currently have the potential to enter the international market. Appropriate translation of company profile is helpful for domestic and foreign enterprises to establish partnerships, so as to promote more in-depth exchanges and research in the field of medicine, and jointly promote the development of human health, which has certain practical significance and value.
However, this paper still has the following deficiencies to be improved. First of all, the number of analysis cases selected in this thesis is limited, with insufficient typicality and limited scope of application. Secondly, translation is a subject requiring profound cultural background and extensive knowledge, such as medical knowledge.

Appendix
Appendix I English Pharmaceutical Company Profiles https://www.msd.com/company-overview/ About our company We invent for a more hopeful future.
We aspire to be the premier research-intensive biopharmaceutical company in the world.
For 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of our mission to save and improve lives.
We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.
Today, we continue to be at the forefront of research to prevent and treat diseases that threaten people and animals-including cancer, infectious diseases, such as HIV and Ebola, and emerging animal diseases.

Responsibility
The heart of our mission We believe corporate responsibility is about our health, social, environmental and economic impact on people and communities around the world.

Leadership
The team that guides our work.
Our leaders focus on our mission to save and improve lives around the world. This is the foundation of everything we do.

Our values
Our values represent the very core of our character. They guide every decision and action we take.

Patients first
We are all accountable for delivering high-quality products and services. We aspire to improve the health and wellness of people and animals worldwide and to expand access to our medicines and vaccines. All of our actions must be measured against our responsibility to those who use or need our products. ISSN 2329-9150 2021 Our values are driven by a desire to improve life.

Journal of Social Science Studies
We've built a culture that embraces scientific excellence, operates with the highest standards of integrity, expands access to our products and employs a diverse workforce that values collaboration. https://www.gsk.com/en-gb/about-us/

About us
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. Every day, we help improve the health of millions of people around the world.
Our goal is to be one of the world's most innovative, best performing and trusted healthcare companies.
Our values and expectations are at the heart of everything we do-so that together we can deliver extraordinary impact for our patients and consumers and make GSK a brilliant place to work.
Our values are Patient focus, Transparency, Respect, Integrity.
Our expectations are Courage, Accountability, Development, Teamwork.

What we do
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.

How we do it
Everyone at GSK is focused on our three long-term priorities-Innovation, Performance, Trust, all powered by our performance-focused culture. https://www.jnj.com/about-jnj

About Johnson & Johnson
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That's why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world's largest and most broadly based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.
Every day, our more than 130,000 employees across the world are blending heart, science and ingenuity to profoundly change the trajectory of health for humanity. ISSN 2329-9150 2021

J&J Our Story
We've been caring for people for more than 130 years. Learn more about the history of our company and our people.

Our Commitment to Our People
Diversity is a core part of our culture.
We've championed women at work, at home and across the world since 1886.

Our Commitment to Innovation
We help entrepreneurs realize their dreams of creating healthcare solutions. Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: "Take what you find here and make it better and better." More than 140 years later, we remain committed to his vision through every aspect of our business and the people we serve starting with those who take our medicines, and extending to health care professionals, employees and the communities in which we live.
Lilly's purpose has never been more important.
When the COVID-19 pandemic shut down the world, Lilly teams jumped in to attack it with everything we could. After an extraordinary year of loss, sacrifice and progress, Lilly scientists and leaders reflect on our purpose and how it powered their urgency and passion to help. Learn more about our global response to COVID-19.

Lilly's Purpose
Lilly unites caring with discovery to create medicines that make life better for people around the world.
Three long-established core values guide all that we do at Lilly. ISSN 2329-9150 2021 We conduct our business consistent with all applicable laws and are honest in our dealings with customers, employees, shareholders, partners, suppliers, competitors and the community.

Excellence
We pursue pharmaceutical innovation, provide high-quality products and strive to deliver superior business results.

Respect for People
We maintain an environment built on mutual respect, openness and individual integrity. This includes our concern for all people who touch or are touched by our company: customers, employees, shareholders, partners, suppliers and communities.
Discovery is our calling.
It's the spirit that has defined us since the day Colonel Eli Lilly opened the doors of our first laboratory in Indianapolis. Over 140 years and nearly 100 medicines later, we keep looking for the next great discovery and for even more ways to make life better for people around the world. https://www.bms.com/about-us/our-company.html

Our Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
At Bristol Myers Squibb, we believe in the power of science to address some of the most challenging diseases of our time. Our focus on these unmet needs comes during a remarkable time, when unprecedented scientific breakthroughs are advancing the treatment of disease as never before in human history.
We work every day to transform patients' lives through science. Each day, our employees around the world work together for patients-they are at the center of everything we do. They inspire us. They are the reason we come to work each day. We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation.
We are proud of the advancements we have made in oncology, hematology, immunology and cardiovascular disease, and we are dedicated to helping patients prevail over serious diseases through our diverse and promising pipelines and new scientific platforms.
As global citizens, we work sustainably and responsibly to create a positive impact in the communities where we live and work. We conduct our global business with the utmost integrity and transparency. We support programs, initiatives and organizations that help improve health, expand research opportunities, promote and expand STEM education and deliver basic human services to our communities.
We know that our responsibility goes beyond medicine. We promote health equity globally and strive to increase access to life-saving medicines for populations disproportionately affected by serious diseases and conditions. We achieve this in part through the Bristol Myers Squibb Foundation, which supports community-based programs that promote cancer awareness, screening, care and support among high-risk populations.

Our Mission and Commitment
Bristol Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.

Leadership
Our culture of inclusion and strong commitment to patients starts at the top.

Governance
Everything we do is guided by our unwavering dedication to our Mission & Commitment.

Principles
We believe that the priceless ingredient of every product we make is the integrity of its maker.

Locations
Find out more about specific Bristol Myers Squibb facilities in North America, Europe, Asia, Latin America.

Doing Business with Us
We do business with companies run by people from diverse backgrounds. Let's work together to create a positive impact on our patients and your business.

Achievements
Our focus is always on helping patients, but it's nice to be recognized for the work we do. https://www.amgen.com/about

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Our belief-and the core of our strategy-is that innovative, highly differentiated medicines that provide large clinical benefits in addressing serious diseases are medicines that will not only help patients, but also will help reduce the social and economic burden of disease in society today.
solutions that improve health outcomes and dramatically improve people's lives. A biotechnology innovator since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Innovative Medicines
We have a presence in approximately 100 countries and regions worldwide and our innovative medicines have reached millions of people in the fight against serious illnesses. We focus on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. Our medicines typically address diseases for which there are limited treatment options, or they are medicines that provide a viable option to what is otherwise available.

Transformative Research
Understanding the fundamental biological mechanisms of disease is a defining feature of Amgen's discovery research efforts-and a major contributor to the development of Amgen's deep and broad pipeline of potential new medicines. Amgen's "biology first" approach permits its scientists to first explore the complex molecular pathways of disease before determining what type of medicine, or modality, is most likely to deliver optimal efficacy and safety. With the advances in human genetics, Amgen continues to shed new light on the molecular roots of disease. Amgen subsidiary deCODE Genetics, a global leader in human genetics, is a powerful differentiator, greatly improving how we identify and validate human disease targets.

World-Class Biomanufacturing
The treatment of millions of seriously ill patients worldwide depends on the safe and reliable production of biologic medicines, which are administered by injection or intravenously. A worldwide leader in biologics manufacturing, Amgen has an outstanding track record of reliably delivering high-quality medicines to patients who need them. Significant skill, experience, vigilance and commitment are critical to help ensure the quality of a biologic medicine each time a new batch is made. At Amgen, robust quality control and a reliable supply of medicines for patients are every bit as important as scientific innovation.
https://www.wyethnutrition.com/ About Wyeth Nutrition A Pioneering Spirit At Wyeth we were founded on an unwillingness to accept the status quo.
We have pioneered infant and young child nutrition since 1915, consistently delivering scientifically-advanced nutrition & personalized solutions for pregnant women, infants and young kids.
Simply put, we never compromise in the pursuit of progress. That's because we serve the most uncompromising people in the world.
And we're proud to say it's helped move us all forward. Our relentless challenging of science for the past 100 years has led to some of the most significant breakthroughs in infant nutrition.
Our responsibility is not only to this generation of children, but to the generations to come, which is why our commitment to quality extends far beyond our products, to the communities we serve through our global and local initiatives.